96 related articles for article (PubMed ID: 16529031)
21. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
Huber KE; Carey LA; Wazer DE
Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer biomarkers and molecular medicine: part II.
Ross JS; Linette GP; Stec J; Clark E; Ayers M; Leschly N; Symmans WF; Hortobagyi GN; Pusztai L
Expert Rev Mol Diagn; 2004 Mar; 4(2):169-88. PubMed ID: 14995904
[TBL] [Abstract][Full Text] [Related]
24. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling in breast cancer: towards individualising patient management.
Murphy N; Millar E; Lee CS
Pathology; 2005 Aug; 37(4):271-7. PubMed ID: 16194824
[TBL] [Abstract][Full Text] [Related]
26. Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.
Pusztai L; Gianni L
Nat Clin Pract Oncol; 2004 Nov; 1(1):44-50. PubMed ID: 16264799
[TBL] [Abstract][Full Text] [Related]
27. Management of breast cancer in the genome era.
Morrow PK; Hortobagyi GN
Annu Rev Med; 2009; 60():153-65. PubMed ID: 19630569
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
29. [Genomic based approach to individualized cancer therapy].
Isomura M; Miki Y
Nihon Rinsho; 2010 Jun; 68(6):1117-20. PubMed ID: 20535965
[TBL] [Abstract][Full Text] [Related]
30. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
[TBL] [Abstract][Full Text] [Related]
32. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
33. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling in breast cancer.
Nasser SM
J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
[TBL] [Abstract][Full Text] [Related]
35. Endocrine therapy for early breast cancer.
Hussain SA; Williams S; Stevens A; Rea DW
Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in molecular genetics of breast cancer.
Pavelić K; Gall-Troselj K
J Mol Med (Berl); 2001 Oct; 79(10):566-73. PubMed ID: 11692153
[TBL] [Abstract][Full Text] [Related]
37. [The value of gene expression profiles using micoarrays for the individualisation of adjuvant therapy after surgery for breast cancer].
Klijn JG; de Vries EG
Ned Tijdschr Geneeskd; 2005 Mar; 149(12):618-22. PubMed ID: 15813427
[TBL] [Abstract][Full Text] [Related]
38. Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
Bertheau P; Turpin E; Rickman DS; Espié M; de Reyniès A; Feugeas JP; Plassa LF; Soliman H; Varna M; de Roquancourt A; Lehmann-Che J; Beuzard Y; Marty M; Misset JL; Janin A; de Thé H
PLoS Med; 2007 Mar; 4(3):e90. PubMed ID: 17388661
[TBL] [Abstract][Full Text] [Related]
39. ROCK: a breast cancer functional genomics resource.
Sims D; Bursteinas B; Gao Q; Jain E; MacKay A; Mitsopoulos C; Zvelebil M
Breast Cancer Res Treat; 2010 Nov; 124(2):567-72. PubMed ID: 20563840
[TBL] [Abstract][Full Text] [Related]
40. An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer.
Scandolara TB; Barreto Pires BR; Vacario B; de Amorim ISS; Siqueira PB; Serpeloni JM; Mencalha AL; Bonvicino CR; Panis C
Curr Top Med Chem; 2022; 22(20):1654-1673. PubMed ID: 35927918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]